Tebentafusp in metastatic uveal melanoma

Tebentafusp, a bispecific protein, consists of a soluble affinity-enhanced T-cell receptor fused to an anti-CD3 effector that can direct T cells to target glycoprotein 100-positive cells.

HLA: human leukocyte antigen; CD3: cluster of differentiation 3.

From: Nathan P, Hassel JC, Rutkowski P, et al. Overall survival benefit with tebentafusp in metastatic uveal melanoma. N Engl J Med. 2021 Sep 23;385(13):1196-1206. Copyright © 2021 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.

Graphic 135190 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟

خرید پکیج

Tebentafusp in metastatic uveal melanoma